Jane Street’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-48,100
Closed -$1.51M – 12587
2026
Q2
$1.51M Sell
48,100
-1,800
-4% -$76K ﹤0.01% 5685
2026
Q1
$2.76M Buy
49,900
+41,700
+509% +$1.98M ﹤0.01% 4494
2025
Q4
$306K Buy
+8,200
New +$333K ﹤0.01% 8799

Other funds holding PAHC

Jane Street's PAHC Position: Q3 2026 in Review

Jane Street reduced its Phibro Animal Health (PAHC) stake by 7.9% in Q3 2026, selling an estimated $26.5K and leaving 8,772 shares worth $314K. The position accounts for ﹤0.01% of the portfolio, ranked #9079.

Jane Street first reported a position in PAHC in Q2 2014 and has held it in 15 quarters since. The position peaked at $2.41M in Q4 2025. 236 funds tracked by Wall St. Rank hold PAHC as of Q3 2026.

  • Jane Street held 8,772 shares of Phibro Animal Health worth $314K as of Q3 2026.
  • Jane Street sold 754 Phibro Animal Health shares in Q3 2026, an estimated $26.5K.
  • Phibro Animal Health made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #9079 holding.
  • Jane Street first reported a position in Phibro Animal Health in Q2 2014 and has held it in 15 quarters since.
  • Jane Street's Phibro Animal Health position peaked at $2.41M in Q4 2025.
  • 236 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.